Translational Research Skills Development Core
Translational Research Skills Development Core
批准号:
8392583
负责人:
Andrew S Weyrich
金额:
$11.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2017-04-30
关键词:
Applications GrantsAwardBasic ScienceBloodBlood ClotBlood PlateletsBlood coagulationBostonCellsClinicalClinical InvestigatorClinical SciencesClinical TrialsCritiquesDataDevelopmentDisciplineDiseaseDoctor of PhilosophyEducationEducational CurriculumEducational workshopEnrollmentEnvironmentFacultyFosteringFunctional disorderGlucoseGoalsGrantHuman BiologyInstitutesInstitutional National Research Service AwardInstructionJournalsLipidsMedicalMedical StudentsMedicineMentorsMetabolicMetabolic syndromeMetabolismMolecularMolecular MedicineNon-Insulin-Dependent Diabetes MellitusObesityPatient EducationPhysiciansPostdoctoral FellowRegulationResearchResearch InfrastructureResearch PersonnelResearch TrainingRiskScientistSenior ScientistStagingStudentsSupervisionThrombosisTissuesTrainingTraining ProgramsTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesUtahWritingbench to bedsidecareerclinically relevantdiabetes managementexperiencegraduate studentinsightkillingspost-doctoral trainingpre-doctoralprogramsskills
中文摘要
项目总结(见说明):
翻译和研究技能开发核心(核心D)将是犹他大学分子医学和血栓翻译研究中心(U2M2-TRCT)培训年轻研究人员的主要工具。CORE D将利用犹他大学现有的基础设施,这样做将为处于不同职业阶段的医学博士和医学博士科学家提供独特的培训环境。这包括利用犹他大学转化科学临床中心(CCTS)、四个T32计划、HHMI医学博士研究生科学家培训计划、医学博士计划和医学生暑期研究计划。所有这些项目都由U2M2-TRCT调查人员指导或联合指导。CORE D将利用这一基础设施为年轻研究人员为与新陈代谢和/或血栓形成相关的板凳到床边研究职业生涯做好严格的准备。核心为所有类型的年轻投资人提供深入而有凝聚力的教育计划。本课程包括专注于新陈代谢和血栓形成的专业课。核心D还包括个性化指导,包括
U2M2-TRCT成立了科学家,将向年轻研究人员介绍基础研究和翻译研究的细节。核心D的一个主要目标将是帮助年轻研究人员为竞争性拨款申请生成初步数据。同时,青年研究人员将参加赠款编写讲习班和正在进行的研究会议,为介绍和批评
研究计划。U2M2-TRCT项目已经包括了几名年轻的和新兴的研究人员,他们参与了本报告的准备工作。这些研究人员此前曾与U2M2-TRCT资深科学家一起接受培训,成功申请并获得了年轻研究人员奖,并正在迈向独立研究生涯的道路上。核心D将继续提供一个肥沃的环境,促进
这些研究人员和其他医学博士、博士和医学博士实习生的发展将在未来几年进入该项目。
英文摘要
PROJECT SUMMARY (See instructions):
The Translational and Research Skills Development Core (Core D) will be the primary vehicle by which the University of Utah Molecular MedicineTranslational Research Center in Thrombosis (U2M2-TRCT) trains young investigators. Core D will take advantage of existing infrastructure at the University of Utah and, in doing so, will provide a unique training environment for MD, PhD, and MD-PhD scientists at various career stages. This includes utilization of the University of Utah Clinical Center in Translational Science (CCTS), four T32 programs, a HHMI med-to-grad PhD scientist training program, the MD-PhD program, and the Medical Student Summer research program. All of these programs are directed or co-directed by U2M2-TRCT investigators. Core D will use this infrastructure to rigorously prepare young investigators for bench to-bedside research careers related to metabolism and/or thrombosis. The Core provides an in-depth and cohesive education program for all types of young invesfigators. This curriculum includes specialized classes that focus on metabolism and thrombosis. Core D also includes individualized mentoring with
U2M2-TRCT established scientists that will introduce young investigators to the ins-and-outs of basic and translational research. A primary objective of Core D will be to help young investigators generate preliminary data for competitive grant applications. In parallel, the young investigators will participate in grant writing workshops and research-in-progress sessions that provide a platform for presentation and critique of
research plans. The U2M2-TRCT program already includes several young and emerging investigators who participated in preparing this submission. These investigators have previously trained with U2M2-TRCT senior scientists, have successfully applied and received young investigator awards, and are well on their way to independent research careers. Core D will continue to provide a fertile environment that fosters the
development of these investigators and other MD, PhD, and MD-PhD trainees who will enter the program over the next several years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10616557
-
项目类别:
-
资助金额:$71.22万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10569253
-
项目类别:
-
资助金额:$73.09万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
-
批准号:8784662
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2014
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8464249
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8464247
-
项目类别:
-
资助金额:$62.26万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Administrative
-
批准号:8391960
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8391959
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8464229
-
项目类别:
-
资助金额:$252.4万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:9068226
-
项目类别:
-
资助金额:$252.7万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8656415
-
项目类别:
-
资助金额:$261.08万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Human and Mouse Cell Isolation and Phenotyping
-
批准号:8391963
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8250544
-
项目类别:
-
资助金额:$266.69万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Molecular Regulation of Platelet Reprogramming by the Metabolic Milieu
-
批准号:8391955
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Metabolic Regulation of Platelet Reprogramming
-
批准号:8391957
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Role of the Metabolic Milieu In Regulating Platelet Reprogramming in Humans
-
批准号:8391958
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8391962
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
PAR-04-122 Extramural Facilities Construction Grant. "F*
-
批准号:7000557
-
项目类别:
-
资助金额:$800.0万
-
财政年份:2010
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7845031
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Novel Thrombotic and Inflammatory Activities of Platelets in Sepsis
-
批准号:7851203
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7359528
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
海外基金